# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T15:48:36.509455
**Route:** Direct Google API + PDF
**Paper Hash:** 2da73b5f993e9809
**Tokens:** 18318 in / 975 out
**Response SHA256:** 7527a16bad153e08

---

I have reviewed the draft paper "The Symmetric Test: Drug Decriminalization and Recriminalization in Oregon" for fatal errors. Below is my assessment.

### FATAL ERROR 1: Data-Design Alignment
**Location:** Page 1 (Abstract), Page 6 (Section 3.1), Page 29 (Section A.2)
**Error:** The paper claims to use data through September 2025 to study a recriminalization policy that took effect in September 2024. However, the paper is dated March 10, 2026, and explicitly states (on page 29) that "Data were accessed in January 2026." While the timeline is chronologically possible, the CDC VSRR data used has a known, significant reporting lag. The paper acknowledges on page 6 and page 25 that there is a "6–8 month" lag for final counts and that provisional data for the most recent months "may undercount deaths."
**Fix:** The "Design 2" results (post-September 2024) rely on the most recent and least reliable portion of the provisional data. To avoid a fatal misalignment where the treatment effect is confounded by incomplete reporting lags, the student must either: (a) apply a validated correction factor for reporting lags, or (b) truncate the analysis to include only months with at least 80-90% completeness as defined by the CDC.

### FATAL ERROR 2: Internal Consistency (Data vs. Tables)
**Location:** Table 1 (page 7) vs. Section 3.1 (page 6)
**Error:** Section 3.1 states the analysis sample covers "January 2015 through September 2025," totaling "up to 129 months." With 51 units, this should yield $129 \times 51 = 6,579$ observations. Table 3 notes also confirm $N=6,579$. However, Table 1 reports summary statistics for "Oregon: Recriminalized" and "Others: Recriminalized Era" based on a period starting September 2024. Given the 12-month-ending nature of the outcome, the first "pure" post-treatment month for recriminalization would be September 2025. Table 1 reports a mean Fentanyl Rate for Oregon in the recriminalized phase of 22.1, but Figure 4 and Figure 8 show the rate sharply declining during this specific window. The statistics in Table 1 for the "Recriminalized" period (specifically the Heroin Rate of 0.5 and Fentanyl Rate of 22.1) seem to represent a single point-in-time or an extremely small $N$ that contradicts the "12-month-ending" smoothing described in the text.
**Fix:** Ensure Table 1 means for the "Recriminalized" phase are calculated correctly over the full 13-month window mentioned in the text (Sept 2024–Sept 2025) and that the $N$ for each sub-period is explicitly reported to ensure no observations were dropped.

### FATAL ERROR 3: Regression Sanity / Internal Consistency
**Location:** Table 3 (page 17) and Table 4 (page 19)
**Error:** In Table 3, the "Decriminalization" ATT is 10.888. In Table 4, the "Synthetic Opioids" component is 9.048 and "Psychostimulants" is 3.611. The paper correctly notes that these subcategories are not mutually exclusive (as one death can involve both). However, the "Share of Total" column in Table 4 calculates percentages (83.1%, 33.2%, etc.) based on the 10.888 denominator. This is mathematically misleading because the sum of the drug-specific ATTs ($9.048 + 3.611 + 1.320 - 0.227 = 13.752$) significantly exceeds the total ATT (10.888). 
**Fix:** The "Share of Total" column is logically broken if the categories overlap. It should be removed or replaced with a "Contribution to Gap" metric that accounts for co-involvement, or the text must explicitly state that these are not additive shares of a whole.

**ADVISOR VERDICT: FAIL**